Cargando…
中国非小细胞肺癌免疫检查点抑制剂治疗专家共识（2019年版）
Non-small cell lung cancer (NSCLC) is the most common pathological type of lung cancer, most NSCLC patients are at advanced stage at the time of diagnosis. For patients without sensitive driven-oncogene mutations, chemotherapy is still the main treatment at present, the overall prognosis is poor. Im...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049793/ https://www.ncbi.nlm.nih.gov/pubmed/32093450 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.02.01 |